FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga

被引:287
作者
Aartsma-Rus, Annemieke [1 ]
Krieg, Arthur M. [2 ]
机构
[1] Leiden Univ, Med Ctr, Postzone S4-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
[2] Checkmate Pharmaceut, Cambridge, MA USA
关键词
regulatory; oligonucleotide; splicing modulation; therapy;
D O I
10.1089/nat.2016.0657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
[No abstract available]
引用
收藏
页码:1 / +
页数:4
相关论文
共 6 条
[1]
[Anonymous], 2016, SAR SPONS SAT S WORL
[2]
Goemans NM, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0161955, 10.1371/journal.pone.0164684]
[3]
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy [J].
Mendell, Jerry R. ;
Goemans, Nathalie ;
Lowes, Linda P. ;
Alfano, Lindsay N. ;
Berry, Katherine ;
Shao, James ;
Kaye, Edward M. ;
Mercuri, Eugenio ;
Hamid, Hoda Abdel ;
Byrne, Barry J. ;
Connolly, Anne M. ;
Dracker, Robert A. ;
Frank, L. Matthew ;
Heydemann, Peter T. ;
O'Brien, Kevin C. ;
Sparks, Susan E. ;
Specht, Linda A. ;
Rodino-Klapac, Louise ;
Sahenk, Zarife ;
Al-Zaidy, Samiah ;
Cripe, Linda H. ;
Lewis, Sarah ;
Pane, M. ;
Mazzone, E. ;
Messina, Sonia ;
Vita, G. L. ;
D'Amico, A. ;
Bertini, E. S. ;
Berardinelli, A. ;
Torrente, Y. ;
Magri, F. ;
Comi, G. P. ;
Baranello, G. ;
Mongini, T. ;
Pini, A. ;
Battini, R. ;
Pegoraro, E. ;
Bruno, C. ;
Politano, L. ;
Previtali, S. .
ANNALS OF NEUROLOGY, 2016, 79 (02) :257-271
[4]
Eteplirsen for the Treatment of Duchenne Muscular Dystrophy [J].
Mendell, Jerry R. ;
Rodino-Klapac, Louise R. ;
Sahenk, Zarife ;
Roush, Kandice ;
Bird, Loren ;
Lowes, Linda P. ;
Alfano, Lindsay ;
Gomez, Ann Maria ;
Lewis, Sarah ;
Kota, Janaiah ;
Malik, Vinod ;
Shontz, Kim ;
Walker, Christopher M. ;
Flanigan, Kevin M. ;
Corridore, Marco ;
Kean, John R. ;
Allen, Hugh D. ;
Shilling, Chris ;
Melia, Kathleen R. ;
Sazani, Peter ;
Saoud, Jay B. ;
Kaye, Edward M. .
ANNALS OF NEUROLOGY, 2013, 74 (05) :637-647
[5]
Exon skipping: a first in class strategy for Duchenne muscular dystrophy [J].
Niks, Erik H. ;
Aartsma-Rus, Annemieke .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (02) :225-236
[6]
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy [J].
Straub, Volker ;
Balabanov, Pavel ;
Bushby, Kate ;
Ensini, Monica ;
Goemans, Nathalie ;
De Luca, Annamaria ;
Pereda, Alejandra ;
Hemmings, Robert ;
Campion, Giles ;
Kaye, Edward ;
Arechavala-Gomeza, Virginia ;
Goyenvalle, Aurelie ;
Niks, Erik ;
Veldhuizen, Olav ;
Furlong, Pat ;
Stoyanova-Beninska, Violeta ;
Wood, Matthew J. ;
Johnson, Alex ;
Mercuri, Eugenio ;
Muntoni, Francesco ;
Sepodes, Bruno ;
Haas, Manuel ;
Vroom, Elizabeth ;
Aartsma-Rus, Annemieke .
LANCET NEUROLOGY, 2016, 15 (08) :882-890